<PAGE> 1
FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Progressive Angioplasty Systems, Inc.
(Exact name of Registrant as specified in its charter)
Delaware 94-3245389
(State of incorporation or organization) (IRS Employer I.D. No.)
1350 Willow Road, Suite 201, Menlo Park, California, 94025
(Address of principal executive offices)
Securities to be registered pursuant to Section 12(b) of the Act:
NONE
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, $.001 par value
<PAGE> 2
Item 1. Description of Registrant's Securities to be Registered
Incorporated by reference to page 47 through 48 of the
Preliminary Prospectus, contained in Registrant's Registration
Statement on Form SB-2 filed on June 19, 1996 (the "SB-2
Registration Statement").
Item 2. Exhibits
The following exhibits are filed as a part of this registration
statement:
1.* Specimen certificate for Registrant's Common Stock;
2.** Restated Certificate of of Incorporation, as currently in
effect;
3.*** Form of Restated Certificate of Incorporation to be filed
after the closing of the offering made under the SB-2
Registration Statement.
- ---------------
* Incorporated by reference to Exhibit 4.1 to the SB-2 Registration Statement.
** Incorporated by reference to Exhibit 3.1 to the SB-2 Registration Statement.
*** Incorporated by reference to Exhibit 3.2 to the SB-2 Registration Statement.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has duly caused this Registration Statement to be signed
on its behalf by the undersigned, thereto duly authorized.
Date: August 7, 1996
PROGRESSIVE ANGIOPLASTY SYSTEMS, INC.
By: /s/ ROBERT HESS
-------------------------------------------------
Robert Hess, President & Chief Executive Officer
-2-
